Transscatheter aortic valve replacement is a novel way to replace a diseased aortic valve without a median sternotomy. The first human TAVR was performed by Dr. Cribier in 2002. [33] There have ...
Edwards Lifesciences on Thursday forecast fourth-quarter sales below Wall Street estimates, hurt by softer demand and fierce competition for its artificial heart valves. Investor expectations for ...
In moderate cases of aortic stenosis, people may need to monitor the condition and follow a heart-healthy lifestyle. In severe cases, people may need an aortic valve replacement.